Koshinski Asset Management, Inc. Vista Gen Therapeutics, Inc. Transaction History

Koshinski Asset Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 14, 2022	SELL	$1.67 - $2.76 $6,012 - $9,936	-3,600 Closed	0 $0
Q3 2021 Oct 12, 2021	BUY	$2.62 - $3.45 $9,432 - $12,420	3,600 New	3,600 $0
Q1 2021 May 06, 2021	SELL	$1.89 - $2.96 $43,092 - $67,488	-22,800 Closed	0 $0
Q4 2020 Mar 30, 2021	BUY	$0.65 - $1.94 $7,410 - $22,116	11,400 Added 100.0%	22,800 $44,000
Q4 2020 Feb 05, 2021	BUY	$0.65 - $1.94 $7,410 - $22,116	11,400 New	11,400 $44,000
Q4 2020 Feb 02, 2021	SELL	$0.65 - $1.94 $13,000 - $38,800	-20,000 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$0.3 - $1.41 $6,000 - $28,200	20,000 New	20,000 $14,000
Q2 2019 Jul 18, 2019	SELL	$0.54 - $1.33 $10,800 - $26,600	-20,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$1.1 - $1.76 $22,000 - $35,200	20,000 New	20,000 $26,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $623M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Koshinski Asset Management, Inc. with notifications on news.